Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
A more detailed report and how it could be beneficial to the medical cannabis sector in Europe and the UK
https://www.proactiveinvestors.com/companies/news/1023712/german-cabinet-approves-cannabis-legalisation-hailed-as-turning-point-for-cannabis-market-1023712.html?region=ca
Not sure where's that been all this time and ive seen no declaration RNS for this trade.IMO theres lots of things going on in the background to leave retail investors second guessing but hopefully some northward movement soon despite those tiny trades going through.
If this was to bounce back next week for eg then those small trades would not be the main driver. We are about 30% below the latest issue price of 2.88p so I wouldn't be surprised if they're not being snapped up as the the positive sentiment seems to be hotting up . GLA
Theres been 50% dilution to absorb after sourcing additional funding and based on those small trades it would take forever to bounce back if that's what's really happening.? IMO think again
These reports keep coming and it looks like something positive is behind the continued coverage..
https://news.sky.com/story/adhd-sufferers-are-self-medicating-with-cannabis-because-of-nhs-delays-charity-warns-12933943
Yes If a tobacco company was interested in buying the Kanabo Group then It would be interesting how they would value it If Kanabo products need to be prescribed then that makes the GP service and Treat It more important assets and not so simple to incorporate them into their own portfolio of vapes. I just hope that the Kanabo Group has the time to establish its brand and value in this growing sector before the likes of big tobacco try to muscle in and try to buy it on the cheap.
SYQE MEDICAL for $650m and their main product is a similar to the Kanabo inhaler
https://mjbizdaily.com/philip-morris-buying-israeli-cannabis-firm-for-up-to-650m-report-says/
Whilst the price is still flagging it does not reflect on the sentiment thats growing
https://www.proactiveinvestors.co.uk/companies/news/1021029/gps-prescribing-cannabis-could-ease-nhs-wait-times-report-1021029.html
This big publicised crackdown looks more like the governments attempt to clear the way for the legal route as they are fully aware potential revenues that lie ahead. The sector could be ready to make a big move forward despite what the stock prices are saying and these raids are a positive step towards that..
Https://www.thisismoney.co.uk/money/article-12259611/SMALL-CAP-IDEA-Cannabis-businesses.html
30th June 22 last AGM
The Medical Cannabis prescription figures released in Guernsey look very promising
https://www.itv.com/news/channel/2023-06-08/guernsey-gives-out-12000-cannabis-prescriptions-in-10-months
Its a year today since the last AGM and with another one due shortly then it would be good to see it supported with some encouraging news
Yes its great having him onboard and it gives confidence to the market especially with his investment however from the inflated IPO price we have seen it heavily fall with those that bought in at the top end needing more than a miracle compared to his investment price.
New small cap companies prefer the price to fall following an IPO so there's less risk if they need new cash calls because many initial retail investors sitting on big holdings at the higher price are not affiliated with the company making it difficult to raise cash from them hence bringing Ian Mattoli onboard at a far lower risk to him than the initial retail investors and they achieve another cash injection. He was also given a seat on the board but I just hope he stays around with his investment until this gets back closer to the initial IPO price.
Still waiting for the proposed date of the AGM and all resolutions to be passed including those shares allocated to the officers and directors.
Tomorrow will bring another admission of shares associated with the purchase of the GP Service and with the AGM announcement due hopefully with both behind us we can see some upward movement from the current level. Over the last month we have seen the total issued shares increased by approx 20% so hopefully from here we can see some meat on the bones from the company to justify their current dilution strategy.
Obviously as the share price has crashed since the debt facility loan was made and where the price is now then it's not beneficial to issue the shares to MIEF as the exercise price was 12.65p per share..With them obtaining an extension to Dec 24 then they must be confident in reaching this price with the option to issue them sooner.than the extension deadline . Lets hope their confidence translates into the share price rebound and this exercise price is surpassed in the short to medium term with long term holders believing they can also profit from their investment too.
RNS released confirming this news and and that existing shareholders will have to apply for a share of the £200k worth of shares that will be made available to purchase out of the £2.54M raise that has already been purchased by the big boys. Confidence is growing and it looks like any shares that are available and sold from here will be easily snapped up.
Judging by the frequent ramped up press coverage it looks like the Cannabis sector could be ready to breakout and if so they will probably need the cash to respond especially once they've gained the CE mark and also supplying the EU. Looks like the new chairs investment came with an agreement to be appointed to the board. His investment shows confidence that will attract other big investors as he's well known in the city . With only 423M shares there doesn't seem to be many free shares available and it will be interesting to see who these new shares are made available to and at what discount price as there could be a strong demand growing. Whatever happens im just hoping this news is beneficial to retail investors.